Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has provided an announcement.
Shanghai Heartcare Medical Technology Corp. Ltd. announced a change in its supervisory committee with the appointment of Mr. Liu Hongbao as the new Employee Representative Supervisor. This change follows the resignation of Mr. Liu Baiwei due to personal work arrangements, who also served as the Chairman of the Supervisory Committee. The company expressed gratitude for Mr. Liu Baiwei’s contributions and clarified that there are no disagreements or pending claims related to his resignation. Mr. Liu Hongbao, who has extensive experience in sales and marketing of medical devices, will not receive remuneration for his role as Employee Representative Supervisor.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai Heartcare Medical Technology Corp. Ltd. operates in the medical technology industry, focusing on the development and sales of medical devices. The company is known for its expertise in neurointervention and has a market focus on innovative healthcare solutions.
Average Trading Volume: 127,217
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.96B
See more data about 6609 stock on TipRanks’ Stock Analysis page.